FDA NDC Directory · JSON-LD · Markdown

DALVANCE

NDC 57970-100 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION

Generic nameDalbavancin
Labeler / ManufacturerAllergan, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA021883
Dosage form / routeINJECTION, POWDER, FOR SOLUTION · INTRAVENOUS
Active ingredientsDALBAVANCIN HYDROCHLORIDE (500 mg/25mL)
Marketing started20140523
Package count1

External sources

Source: openFDA. Public-domain (CC0).